查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590640

女性用避孕藥市場：依避孕藥、避孕器具、通路分類 - 全球預測 2025-2030

Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年女性用避孕藥市場價值為93.2億美元，預計2024年將達到99.1億美元，複合年成長率為6.41%，到2030年將達到144億美元。

女性用避孕藥具市場包括一系列旨在幫助女性預防意外懷孕並有效管理生殖健康的產品和技術。這些避孕藥具的需求源自於對計劃生育、改善性健康和個人生育選擇自主權的持續需求。應用多種多樣，從荷爾蒙避孕藥（如藥丸、貼片和注射劑），到屏障方法（如女性用避孕套和隔膜），再到長效可逆避孕藥（LARC），如子宮內避孕器（IUD ）和皮下植入。最終使用範圍主要是個人消費者、醫療保健提供者和計劃生育診所。根據市場洞察，關鍵的成長要素包括性健康意識的提高、女性就業的增加推動了控制計劃生育的願望以及支持避孕藥具使用的政府政策。技術進步，例如生物分解性且易於管理的避孕方法的開發，具有巨大的市場擴張潛力。然而，挑戰仍然存在，例如某些地區的社會文化阻力、低收入國家獲得醫療保健服務的機會有限，以及與荷爾蒙避孕藥相關的潛在副作用阻礙了其使用。機會在於投資研究和開發可最大限度減少副作用的非荷爾蒙避孕藥，以及提供個人化避孕建議的創新數位健康解決方案。此外，透過教育努力開拓新興市場也能收穫紅利。限制包括監管障礙和世界某些地區的保守態度，阻礙了採用。有前景的技術創新包括開發男性避孕藥以擴大人口數量，以及生物技術的進步以提供更安全、更有效的解決方案。市場的動態性質、不斷變化的消費者偏好和監管環境需要採取適應性策略來實現永續成長和市場滲透。透過建立跨部門合作並利用新技術平台進行產品開發，我們相信我們可以幫助推動產業發展並解決女性生殖健康方面未被滿足的需求。

主要市場統計
基準年[2023] 93.2億美元
預測年份 [2024] 99.1億美元
預測年份 [2030] 144億美元
複合年成長率（%） 6.41%

市場動態：揭示快速發展的女性用避孕市場的關鍵市場洞察

供需的動態交互作用正在改變女性用避孕市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 意外懷孕和性行為感染感染的增加
    • 政府措施提高人們對意外懷孕和人口成長的認知
    • 避孕器的種類和可用性
  • 市場限制因素
    • 避孕藥的副作用
  • 市場機會
    • 避孕方法的可用性，例如植入和新型避孕藥具
    • 支持新興國家避孕激勵計畫的政府和非政府組織
  • 市場挑戰
    • 對各種避孕方法的社會恥辱與誤解

波特五力：開拓女性用避孕市場的策略工具

波特的五力是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解女性用避孕市場的外在影響

外部宏觀環境因素在塑造女性用避孕藥市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解女性用避孕藥市場的競爭格局

對女性用避孕藥具市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV女性用避孕藥具市場供應商定位矩陣績效評估

FPNV定位矩陣是評估女性用避孕藥市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃女性用避孕藥市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對女性用避孕藥市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 意外懷孕和性行為感染感染的發生率增加
      • 政府努力提高人們對意外懷孕和人口成長的認知
      • 避孕器種類繁多且易於獲取
    • 抑制因素
      • 避孕藥的副作用
    • 機會
      • 避孕方法的可用性，例如植入式避孕藥和新的避孕方法
      • 政府和非政府組織支持新興經濟體避孕推廣計劃
    • 任務
      • 對各種避孕方法的社會恥辱與誤解
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章女性用避孕藥分類）

  • 避孕針劑
  • 避孕藥
    • 荷爾蒙藥物
    • 非荷爾蒙藥丸
  • 殺精劑
  • 局部避孕藥

第7章女性用避孕器市場

  • 避孕貼片
  • 避孕海綿
  • 隔膜和蓋子
  • 女性用保險套
  • 子宮內避孕器
  • 皮下植入避孕藥
  • 避孕環

第8章女性用避孕藥市場：依通路分類

  • 診所
  • 醫院藥房
  • 獨立藥房
  • 網路平台

第9章美洲女性用避孕藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太女性用避孕藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲女性用避孕藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Agile Therapeutics
  • Amgen Inc.
  • Ansell Ltd.
  • Bayer AG
  • Cipla Limited
  • Cupid Limited
  • HLL Lifecare Limited
  • Johnson & Johnson Services, Inc.
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals SA
  • Pfizer Inc.
  • The Cooper Companies, Inc.
Product Code: MRR-4348D129FB2D

The Female Contraceptive Market was valued at USD 9.32 billion in 2023, expected to reach USD 9.91 billion in 2024, and is projected to grow at a CAGR of 6.41%, to USD 14.40 billion by 2030.

The female contraceptive market encompasses a broad range of products and technologies aimed at enabling women to prevent unwanted pregnancies and manage reproductive health efficiently. The necessity for these contraceptives stems from the ongoing demand for family planning, improved sexual health, and personal autonomy over reproductive choices. Applications are diverse, spanning from hormonal contraceptives like pills, patches, and injections to barrier methods such as female condoms and diaphragms, as well as long-acting reversible contraceptives (LARCs) including intrauterine devices (IUDs) and subdermal implants. End-use scope primarily involves individual consumers, healthcare providers, and family planning clinics. Market insights suggest that significant growth factors include increased awareness about sexual health, rising female employment driving the desire for controlled family planning, and governmental policies supporting contraceptive use. Technological advancements, such as the development of biodegradable and easy-to-administer methods, offer tremendous potential for market expansion. Nonetheless, challenges persist in the form of socio-cultural resistance in certain regions, limited access to healthcare services in low-income countries, and potential side effects associated with hormonal contraceptives that deter usage. Opportunities lie in investing in R&D for non-hormonal contraceptives that minimize side effects and innovations in digital health solutions that provide personalized contraceptive advice. Moreover, tapping into emerging markets with educational initiatives could pay dividends. Limitations include regulatory hurdles and predominantly conservative attitudes in parts of the world curtailing widespread adoption. For innovation, areas such as the development of male contraceptives to broaden the target audience and advances in biotechnology for safer, more effective solutions are promising. The market's nature is dynamic, with evolving consumer preferences and regulatory landscapes, necessitating adaptive strategies for sustained growth and market penetration. Engaging with cross-sector collaborations and leveraging new technological platforms for product development could bolster industry progress and address unmet needs in women's reproductive health.

KEY MARKET STATISTICS
Base Year [2023] USD 9.32 billion
Estimated Year [2024] USD 9.91 billion
Forecast Year [2030] USD 14.40 billion
CAGR (%) 6.41%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Female Contraceptive Market

The Female Contraceptive Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of unwanted pregnancies and sexually transmitted diseases
    • Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
    • Multiple types and ease of availability of contraceptives
  • Market Restraints
    • Side effects of contraceptive drugs
  • Market Opportunities
    • Availability of contraceptives method such as Sino-Implants and novel contraceptive
    • Government and non-government organizations supporting programs to encourage contraception in emerging economies
  • Market Challenges
    • Social stigma and misconceptions about different contraceptives

Porter's Five Forces: A Strategic Tool for Navigating the Female Contraceptive Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Female Contraceptive Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Female Contraceptive Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Female Contraceptive Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Female Contraceptive Market

A detailed market share analysis in the Female Contraceptive Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Female Contraceptive Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Female Contraceptive Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Female Contraceptive Market

A strategic analysis of the Female Contraceptive Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Contraceptive Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Agile Therapeutics, Amgen Inc., Ansell Ltd., Bayer AG, Cipla Limited, Cupid Limited, HLL Lifecare Limited, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., Merck & Co., Inc., Mithra Pharmaceuticals S.A., Pfizer Inc., and The Cooper Companies, Inc..

Market Segmentation & Coverage

This research report categorizes the Female Contraceptive Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Contraceptive Drug, market is studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills is further studied across Hormonal Pills and Non-Hormonal Pills.
  • Based on Contraceptive Devices, market is studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps, Female Condoms, Intra Uterine Contraceptive Devices, Sub-Dermal Contraceptive Implants, and Vaginal Rings.
  • Based on Distribution Channel, market is studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
      • 5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
      • 5.1.1.3. Multiple types and ease of availability of contraceptives
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of contraceptive drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of contraceptives method such as Sino-Implants and novel contraceptive
      • 5.1.3.2. Government and non-government organizations supporting programs to encourage contraception in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma and misconceptions about different contraceptives
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Female Contraceptive Market, by Contraceptive Drug

  • 6.1. Introduction
  • 6.2. Contraceptive Injections
  • 6.3. Contraceptive Pills
    • 6.3.1. Hormonal Pills
    • 6.3.2. Non-Hormonal Pills
  • 6.4. Spermicides
  • 6.5. Topical Contraceptives

7. Female Contraceptive Market, by Contraceptive Devices

  • 7.1. Introduction
  • 7.2. Contraceptive Patches
  • 7.3. Contraceptive Sponges
  • 7.4. Diaphragms & Caps
  • 7.5. Female Condoms
  • 7.6. Intra Uterine Contraceptive Devices
  • 7.7. Sub-Dermal Contraceptive Implants
  • 7.8. Vaginal Rings

8. Female Contraceptive Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Clinic
  • 8.3. Hospital Pharmacy
  • 8.4. Independent Pharmacy
  • 8.5. Online Platform

9. Americas Female Contraceptive Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Female Contraceptive Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Female Contraceptive Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Afaxys Pharma, LLC
  • 3. Agile Therapeutics
  • 4. Amgen Inc.
  • 5. Ansell Ltd.
  • 6. Bayer AG
  • 7. Cipla Limited
  • 8. Cupid Limited
  • 9. HLL Lifecare Limited
  • 10. Johnson & Johnson Services, Inc.
  • 11. Mankind Pharma Ltd.
  • 12. Merck & Co., Inc.
  • 13. Mithra Pharmaceuticals S.A.
  • 14. Pfizer Inc.
  • 15. The Cooper Companies, Inc.

LIST OF FIGURES

  • FIGURE 1. FEMALE CONTRACEPTIVE MARKET RESEARCH PROCESS
  • FIGURE 2. FEMALE CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEMALE CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FEMALE CONTRACEPTIVE MARKET DYNAMICS
  • TABLE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS & CAPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023